Trial intelligence / Profile preview

CARD: Diupress vs Higroton in Elderly Hypertension

NCT01191450Phase 3Completed

Sponsor
Eurofarma
Start
Aug 2011
Primary completion
Aug 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of Chlorthalidone + amiloride in hypertension (HTN) (2 arms), sponsored by Eurofarma. Primary endpoint: Number of Subjects With Serum Potassium Below 4.0 mEq/l at 12 weeks. Started Aug 2011; status: completed.

02

Drugs

Chlorthalidone + amiloride
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT01191450.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01191450.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call